Alpha Tau Medical Ltd (DRTS NASDAQ) stock market data APIs
$3.844
-0.07(-1.8%)
as of September 15, 2025
Try our APIs with
free plan!
Alpha Tau Medical Ltd Financial Data Overview
Price chart is built with
Anychart
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.
Prev. Close
3.844
Open
3.7726
High
3.9126
Low
3.7726
52 wk Range
2.11-4.3866
Market Cap
327 M
Shares Outstanding
85 043 K
EPS
-0.22
Beta
1.005
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Alpha Tau Medical Ltd data using free add-ons & libraries
Get Alpha Tau Medical Ltd Fundamental Data
Alpha Tau Medical Ltd Fundamental data includes:
- Net Revenue:
- EBITDA: -36 445 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-11
- EPS/Forecast: -0.11
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Alpha Tau Medical Ltd News
New
Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial
– First patient treatment marks successful initiation of multi-center pilot study in Alpha DaRT U.S. pancreatic cancer program – – Study explores Alpha DaRT® combined with chemotherapy in pa...
Alpha Tau to Participate in Five September Investor Conferences
JERUSALEM, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha Da...
Alpha Tau Medical GAAP EPS of -$0.22
* Alpha Tau Medical press release [https://seekingalpha.com/pr/20196614-alpha-tau-announces-second-quarter-2025-financial-results-and-provides-corporate-update] (NASDAQ:DRTS [https://seekingalpha.co...
Alpha Tau files to sell 3.46M ordinary shares by selling shareholders
* Alpha Tau (NASDAQ:DRTS [https://seekingalpha.com/symbol/DRTS]) filed a prospectus to sale 3.46 million ordinary shares. * The company will not receive any proceeds from the sale of ordinary sh...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
